FUNCTIONAL AND MECHANISTIC STUDIES OF DNA TOPOISOMERASES

DNA 拓扑异构酶的功能和机制研究

基本信息

  • 批准号:
    2694646
  • 负责人:
  • 金额:
    $ 28.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1980
  • 资助国家:
    美国
  • 起止时间:
    1980-04-01 至 2002-06-30
  • 项目状态:
    已结题

项目摘要

Our long-term objective is to understand the molecular mechanism and physiological function of multiple DNA topoisomerases. In the current application, we propose to study the roles of the two human topoisomerase II (TOP2) isoforms in chromosomal loop domain organization and apoptotic cell death. Many TOP2-targeted anti-cancer drugs are known to induce apoptotic cell death and high molecular weight (HMW) DNA fragmentation (about 50 kb). These HMW DNA fragments presumably reflect TOP2-mediated excision of chromosomal loop domains in which TOP2 is located at their loop anchorage sites. Strikingly, a similar pattern of HMW DNA fragmentation (predominantly 50 kb) has also been observed in apoptotic cells induced by diverse stimuli many of which are known to induce oxidative stress. The HMW DNA fragmentation has been suggested to be a committed step in the apoptotic cell death process, but the enzyme responsible for HMW DNA fragmentation has not been identified. Our preliminary studies have demonstrated that the two human DNA TOP2 isoforms, TOP2a and TOP2b, can be activated to become DNA cleaving "nucleases" by hydrogen peroxide, a reactive oxygen species (ROS) produced during oxidative stress. Oxidative stress has been suggested to be a potential cellular activation of TOP2b (and/or TOP2a) by hydrogen peroxide during oxidative stress is responsible for HMW DNA fragmentation in apoptotic cells. There are two major specific aims for the current application; (1). Functional studies of human TOP2 isoforms. Two approaches will be employed, identification of TOP2-interacting proteins and generating dominant negative mutant TOP2 cell lines. In addition to testing the roles of TOP2 isoforms in chromosomal loop domains mutated in patients with the Bloom's syndrome (genome instability) and WRN, mutated in patients with the Werner's syndrome (premature aging). (2). To establish the roles of human TOP2 isoforms in HMW DNA fragmentation during apoptotic cell death. We will determine if TOP2 ( and which TOP2 isoform) is activated into a "nuclease" in cells treated with hydrogen peroxide or other agents. We will also determine which TOP2 isoform is responsible for HMW DNA fragmentation during apoptotic cell death.
我们的长期目标是了解分子机制和

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LEROY F LIU其他文献

LEROY F LIU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LEROY F LIU', 18)}}的其他基金

Training in Cancer Pharmacology
癌症药理学培训
  • 批准号:
    7128170
  • 财政年份:
    2005
  • 资助金额:
    $ 28.29万
  • 项目类别:
Training in Cancer Pharmacology
癌症药理学培训
  • 批准号:
    6894915
  • 财政年份:
    2005
  • 资助金额:
    $ 28.29万
  • 项目类别:
Training in Cancer Pharmacology
癌症药理学培训
  • 批准号:
    7292666
  • 财政年份:
    2005
  • 资助金额:
    $ 28.29万
  • 项目类别:
Training in Cancer Pharmacology
癌症药理学培训
  • 批准号:
    7498567
  • 财政年份:
    2005
  • 资助金额:
    $ 28.29万
  • 项目类别:
Training in Cancer Pharmacology
癌症药理学培训
  • 批准号:
    7681012
  • 财政年份:
    2005
  • 资助金额:
    $ 28.29万
  • 项目类别:
Mechanism of Action of TOP2-Directed Anticancer Drugs
TOP2靶向抗癌药物的作用机制
  • 批准号:
    8129544
  • 财政年份:
    2004
  • 资助金额:
    $ 28.29万
  • 项目类别:
Mechanism of Action of TOP2-Directed Anticancer Drugs
TOP2靶向抗癌药物的作用机制
  • 批准号:
    7526710
  • 财政年份:
    2004
  • 资助金额:
    $ 28.29万
  • 项目类别:
Mechanism of action of TOP2-directed anticancer drugs
TOP2靶向抗癌药物的作用机制
  • 批准号:
    7006957
  • 财政年份:
    2004
  • 资助金额:
    $ 28.29万
  • 项目类别:
Mechanism of action of TOP2-directed anticancer drugs
TOP2靶向抗癌药物的作用机制
  • 批准号:
    6782758
  • 财政年份:
    2004
  • 资助金额:
    $ 28.29万
  • 项目类别:
Mechanism of Action of TOP2-Directed Anticancer Drugs
TOP2靶向抗癌药物的作用机制
  • 批准号:
    8307026
  • 财政年份:
    2004
  • 资助金额:
    $ 28.29万
  • 项目类别:

相似海外基金

Understanding and exploiting DNA topoisomerases in cancer biology
了解和利用癌症生物学中的 DNA 拓扑异构酶
  • 批准号:
    10296437
  • 财政年份:
    2021
  • 资助金额:
    $ 28.29万
  • 项目类别:
Understanding and exploiting DNA topoisomerases in cancer biology
了解和利用癌症生物学中的 DNA 拓扑异构酶
  • 批准号:
    10473793
  • 财政年份:
    2021
  • 资助金额:
    $ 28.29万
  • 项目类别:
Structural and mechanistic analysis of type II DNA topoisomerases
II 型 DNA 拓扑异构酶的结构和机制分析
  • 批准号:
    2059935
  • 财政年份:
    2018
  • 资助金额:
    $ 28.29万
  • 项目类别:
    Studentship
Conference: 2016 Gordon Research Seminar on DNA Topoisomerases to be held at Sunday River in Newry, ME on August 6-7, 2016
会议:2016 年戈登 DNA 拓扑异构酶研究研讨会将于 2016 年 8 月 6 日至 7 日在缅因州纽里的 Sunday River 举行
  • 批准号:
    1643077
  • 财政年份:
    2016
  • 资助金额:
    $ 28.29万
  • 项目类别:
    Standard Grant
2014 DNA Topoisomerases in Biology and Medicine Gordon Research Conference
2014 DNA 拓扑异构酶在生物学和医学戈登研究会议
  • 批准号:
    8714782
  • 财政年份:
    2014
  • 资助金额:
    $ 28.29万
  • 项目类别:
Biochemical Analyses of Type II DNA Topoisomerases
II 型 DNA 拓扑异构酶的生化分析
  • 批准号:
    7909236
  • 财政年份:
    2009
  • 资助金额:
    $ 28.29万
  • 项目类别:
DNA TOPOISOMERASES & LATE CELL CYCLE CHECKPOINTS
DNA拓扑异构酶
  • 批准号:
    6976458
  • 财政年份:
    2004
  • 资助金额:
    $ 28.29万
  • 项目类别:
DNA TOPOISOMERASES & LATE CELL CYCLE CHECKPOINTS
DNA拓扑异构酶
  • 批准号:
    6470650
  • 财政年份:
    2001
  • 资助金额:
    $ 28.29万
  • 项目类别:
DNA Topoisomerases and DNA Topology in E. coli
大肠杆菌中的 DNA 拓扑异构酶和 DNA 拓扑
  • 批准号:
    0090880
  • 财政年份:
    2001
  • 资助金额:
    $ 28.29万
  • 项目类别:
    Continuing Grant
DNA TOPOISOMERASES & LATE CELL CYCLE CHECKPOINTS
DNA拓扑异构酶
  • 批准号:
    6327943
  • 财政年份:
    2000
  • 资助金额:
    $ 28.29万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了